CJW: Bromcresol Purple Dye-Binding, Albumin: FDA Product Code 510(k) Clearances, Predicate Lineage, and Recall History (1983 to 2022)
U.S. FDA CDRH three-letter product classification CJW in Clinical Chemistry (21 CFR 862.1035) reconciled across 1983 to 2022.
Review 18 FDA 510(k) clearances, 1 recalled K-numbers, and 1 cumulative 1976 to 2026 CDRH recall notices for CJW: Bromcresol Purple Dye-Binding, Albumin on Predicate Ledger.
| Regulatory Metric | Verified Value |
|---|---|
| Entity Classification | FDA 3-Letter Product Code (CJW, Class 2) |
| Clinical Advisory Specialty | Clinical Chemistry (Panel CH) |
| Cleared FDA 510(k) Submissions (1976 to 2026) | 18 clearances (0 California, 0.0%) |
| Cleared 510(k)s Linked to a Recall Notice | 1 K-numbers (cohort below n >= 20 rate floor) |
| Cumulative Historical Recall Notices (1976 to 2026) | 1 notices (0 Class I, 1 Class II, 0 Class III) |
| Currently Open vs Historical Recall Status | Cumulative 1976 to 2026 FDA archive total (1 notices); verify live open vs terminated status per notice in dossier |
| Implantable and Life-Sustaining Clearances | 0 implantable (0.0%) and 0 life-sustaining |
| Median FDA 510(k) Review Duration | 51 days (90th percentile: 108 days) |
Cumulative recall counts span 1976 to 2026 across U.S. FDA CDRH and openFDA public archives and combine closed historical notices with any currently open field actions. Browse all device cohorts, 20 clinical specialties, Shared 510(k) Predicate Lineage Stage, or reconciliation methodology.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.